Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Real-time Estimate
Cboe BZX
15:27:12 04/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 47.77 USD | +1.75% |
|
+1.67% | -50.06% |
| 11:13am | US companies face rise in cyber attacks | RE |
| 09-01 | Oncology firm Novocure says cyberattack exposed US patient records | RE |
| Market Cap | 68.04B 58.54B 54.94B 50.26B 93.81B 6,432B 94.56B 650B 253B 3,287B 256B 250B 10,586B | P/E 2026 * |
17.5x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 76.76B 66.04B 61.98B 56.7B 106B 7,256B 107B 733B 286B 3,708B 288B 282B 11,942B | EV / Sales 2026 * |
3.59x | EV / Sales 2027 * | 3.29x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Tradegate
| BSX | Real-time | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | +1.77% | ||
| 1 week | +1.67% | ||
| Current month | -1.41% | ||
| 1 month | -2.99% | ||
| 3 months | -2.52% | ||
| 6 months | -34.05% | ||
| Current year | -50.06% |
| 1 week | 46.09 |  | 49.66 |
| 1 month | 46.09 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.76% | +1.67% | -55.62% | -10.66% | 68.04B | |
| -1.45% | -2.25% | +24.25% | +12.21% | 229B | |
| -2.22% | -4.72% | +3.44% | -21.07% | 148B | |
| -0.56% | -1.39% | -19.16% | +19.42% | 131B | |
| +0.15% | -0.79% | +10.54% | +17.80% | 51.75B | |
| +0.61% | -1.01% | -17.01% | -14.15% | 50.21B | |
| -0.34% | -3.03% | +16.12% | +25.65% | 42.28B | |
| -1.50% | -1.76% | +35.94% | +47.43% | 40.63B | |
| -1.08% | -6.00% | -17.49% | +46.80% | 33.06B | |
| -2.64% | -0.21% | +120.25% | +34.94% | 33.47B | |
| Average | -0.72% | -1.73% | +10.13% | +15.84% | 82.71B | |
| Weighted average by Cap. | -0.94% | -1.92% | +6.10% | +8.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.38B 17.25B 15.78B 29.46B 2,020B 29.69B 204B 79.47B 1,032B 80.23B 78.48B 3,324B | 22.33B 19.21B 18.03B 16.49B 30.78B 2,111B 31.03B 213B 83.05B 1,079B 83.84B 82.01B 3,474B |
| Net income | 3.84B 3.3B 3.1B 2.84B 5.29B 363B 5.34B 36.67B 14.28B 185B 14.42B 14.1B 597B | 3.69B 3.17B 2.98B 2.72B 5.08B 348B 5.12B 35.21B 13.71B 178B 13.84B 13.54B 574B |
| Net Debt | 8.72B 7.5B 7.04B 6.44B 12.02B 824B 12.11B 83.26B 32.42B 421B 32.73B 32.02B 1,356B | 5.45B 4.69B 4.4B 4.03B 7.52B 515B 7.58B 52.07B 20.28B 263B 20.47B 20.03B 848B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/09/26 | US$47.56 | +1.29% | 2,264,473 |
| 03/09/26 | US$46.95 | -2.94% | 19,732,249 |
| 02/09/26 | US$48.37 | +0.60% | 17,017,972 |
| 01/09/26 | US$48.08 | -0.46% | 12,004,264 |
| 31/08/26 | US$48.30 | +3.12% | 18,906,225 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
